entrinsic bioscience Strengthens Leadership Team with Appointment of Mario Wanderley as Chief Financial Officer and Accelerates Product Development with New Research Facility

UF startup and UF Innovate | Sid Martin Biotech resident client entrinsic bioscience (EBS), a company pioneering a next-generation protein modulation technology, announced the appointment of Mario Wanderleyas Chief Financial Officer. Mr. Wanderley brings 23 years of financial, operational, and strategic expertise to EBS, with significant experience in the medical device, technology, software, telecommunications, and […]

UF Innovate | Tech Licensing Celebrates Best Year Ever

University of Florida researchers made more discoveries and licensed more technologies than ever in the fiscal year just ended, despite the coronavirus pandemic influencing the third and fourth quarters. Researchers disclosed 393 new discoveries and UF Innovate | Tech Licensing signed a record 132 licenses and options, up from 331 disclosures and 122 licenses last […]

Oxidien Announces Publication of Clinical Results Demonstrating Significant Reduction in Urinary Oxalate

UF Innovate | The Hub resident client Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company mitigating kidney stone disease by treating secondary hyperoxaluria, announced the publication of data from a clinical study on the effectiveness of its highly potent and acid-stable Oxalate Decarboxylase (OxDC) to reduce urinary oxalate in subjects on a high oxalate diet. The study was […]

Customized Gene Therapies Successfully Target Rare Eye Diseases

Can gene therapies be effective for the treatment of rare genetic diseases? One company may have found a solution that incorporates a high degree of customization, manufacturing expertise, and years’ worth of knowledge. Having been with Applied Genetic Technologies Corporation (AGTC) for almost 20 years, CEO Sue Washer has first-hand experience in seeing novel ideas […]

Bioscience Firm Makes Progress on Another Kind of Vaccine

The word vaccine carries heavy weight these days, with its tantalizing possibilities to curb the destruction brought on by a certain C-word. But for UF startup and UF Innovate | Sid Martin Biotech alumni company Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, the word vaccine is connected to a different kind of C-word: cancer. […]